Company profile

AIQ Global, Inc.

AIQ Global, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on September 5, 2024 and the most recent on September 5, 2024 (TRAQinform IQ). Its most common review panel is Radiology (1 device).

1AI devices
2024First decision
2024Latest decision
1Specialties

Timeline

  1. TRAQinform IQ · Radiology · LLZ